Brookstone Capital Management Precigen, Inc. Transaction History
Brookstone Capital Management
- $7.5 Billion
- Q4 2025
Shares
2 transactions
Others Institutions Holding PGEN
# of Institutions
193Shares Held
196MCall Options Held
6.61MPut Options Held
2.06M-
Third Security, LLC83.5MShares$385 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD26.5MShares$122 Million4.02% of portfolio
-
Tang Capital Management LLC San Diego, CA12.4MShares$57.2 Million1.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$48.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$47.2 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $960M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...